ArriVent BioPharma, Inc. (AVBP) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 773.87M |
| Enterprise Value | 728.34M |
| P/E Ratio | -5.71 |
| PEG Ratio | -1.58 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 2.73 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -5.38 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.41 |
| Return On Equity | -0.5 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -166.31M |
| Net Income | -166.31M |
| Diluted EPS | -4.32 |
| Total Cash | 373.12M |
| Total Cash/Share | 7.84 |
| Total Debt | 351,000 |
| Total Debt/Equity | 0 |
| Current Ratio | 14.16 |
| Book Value Per Share | 7.71 |
| 52-Week Change | 12.9 |
| 52-Week High | 35.83 |
| 52-Week Low | 11.36 |
| Moving Average 50 Days | 26.16 |
| Moving Average 200 Days | 27.09 |
| Average Volume | 1.07M |
| Shares Outstanding | 49.31M |
| % Held by Institutions | 103.02 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |